Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation

scientific article

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation is …
instance of (P31):
scholarly articleQ13442814

External links are
P932PMC publication ID81330
P698PubMed publication ID11517646

P2093author name stringF A McAlister
K K Teo
A M Buchan
A Shuaib
W A Ghali
L B Mitchell
R T Tsuyuki
T J Bungard
A J Cave
P G Hamilton
P2860cites workWhy do patients with atrial fibrillation not receive warfarin?Q33815598
Physician variation in anticoagulating patients with atrial fibrillation. Dartmouth Primary Care COOP ProjectQ68697007
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsQ72030226
Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderlyQ72440457
The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation InvestigatorsQ73414845
P433issue3
P407language of work or nameEnglishQ1860
P921main subject(RS)-warfarinQ407431
Atrial FibrillationQ815819
P304page(s)301-302
P577publication date2001-08-01
P1433published inCanadian Medical Association JournalQ5030320
P1476titlePhysicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation
P478volume165

Reverse relations

cites work (P2860)
Q24803243A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]
Q37203662Capsule commentary on Efird et al., identifying the risks of anticoagulation in patients with substance abuse
Q35636477Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials?
Q39631749Evaluating the Usability and Perceived Impact of an Electronic Medical Record Toolkit for Atrial Fibrillation Management in Primary Care: A Mixed-Methods Study Incorporating Human Factors Design
Q37453028Explicit risk in acute coronary syndrome management
Q35806598Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study.
Q34087971Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians.
Q34100740Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
Q30830699Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial.
Q35790677Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial
Q37149490International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation
Q28190407New treatment options for stroke prevention in atrial fibrillation
Q35906247Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study
Q92378495Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry
Q35827933The decision to anticoagulate: assessing whether benefits outweigh the risks for patients with atrial fibrillation
Q36951700Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.
Q36472606What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaire.

Search more.